3LJ-11558-25729
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 945 / CA
- Registered
- 2021-05-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-28
Dose 1 — Pfizer-BioNTech
-
2021-05-19
Registered in v-safe
-
2021-05-19
Dose 2 — Pfizer-BioNTech
- 2021-05-19
-
2021-05-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-21
- 2021-05-22
- 2021-05-23
- 2021-05-25
-
2021-05-26
Survey response — day 7, dose 2MedDRA: Eye disorder — Feeling: Good · HeadacheFree text: Eyes sensitiveMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-02
- 2021-06-09
- 2021-06-16
- 2021-06-23
- 2021-06-30
- 2021-08-18
- 2021-11-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-28 | Pfizer-BioNTech | |
| 2 | 2021-05-19 | Pfizer-BioNTech |
Free text
Release 8 — day 7, dose 2
Systemic reaction (other): Eyes sensitive
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Eye disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release